Your browser doesn't support javascript.
loading
Polysomnographic Characteristics and Prescription Status of Restless Legs Syndrome Patients in Naturalistic Setting / 수면정신생리
Sleep Medicine and Psychophysiology ; : 35-40, 2013.
Article in Korean | WPRIM | ID: wpr-8445
ABSTRACT

OBJECTIVES:

The aim of this study is to evaluate the polysomnographic characteristics and prescription status of restless legs syndrome (RLS) patients in naturalistic setting.

METHODS:

We reviewed medical record of the patients over 18 years olds who (i) satisfied the clinical RLS diagnostic criteria and (ii) had the polysomnography and got treatment related thereto. As a baseline, we evaluated the four diagnostic criteria of the International Restless Legs Syndrome Study Group (IRLSSG) and the International Restless Legs Scale (IRLS) of the subjects. Then the polysomnography and the suggested immobilization test (SIT) were conducted and, after one month of pharmacotherapy using dopamine agonist, the IRLS was evaluated again.

RESULTS:

A total of 211 subjects participated in this analysis and 94 (44.5%) of them were male and the other 117 (55.5%) were female and the average age of the 211 subjects was 46.9+/-14.2. Out of such 211 subjects, 136 subjects (64.5%) also had the obstructive sleep apnea (OSA), and 53 subjects (25.1%) also had the periodic limb movement disorder (PLMD). 185 subjects (87.7%) out of the 211 subjects had some other sleep disorders except RLS. The results of the polysomnography were as follows 78.0% of sleep efficiency, 86.8 min of wake after sleep onset, and 3.4% of N3. More specifically, 12.4/h of the average apnea hypopnea index, 14.8/h of the periodic limb movement during sleep (PLMS), 41.2/h of the periodic limb movement during wake during SIT and 21.6/h of total arousal index during sleep. Out of the total subjects, 149 (70.6%) of them took the ropinirole and 47 (22.3%) of them took the pramipexole, and the average dosage of ropinirole was 0.9mg(dosage range 0.125-5 mg) while the average dosage of pramipexole was 0.5 mg (dosage range 0.125-4 mg). The dosage of the ropinirole showed a significant positive correlation with the age (r=0.25, p=0.002) and also with the IRLS (r=0.23, p=0.038). The IRLS at the baseline was 24.9 while the same was decreased down to 13.4 after one month.

CONCLUSIONS:

Analyzing the result of this study, a majority of clinical RLS subjects demonstrated comorbidity with some other sleep disorder such as the OSA or PLMD. 25.1% of the subjects showed a PLMD, which was less than in previous researches and the average PLMS was not very high as 14.8/h. The dosage of dopamine agonist taken was often a bit more than the amount recommended in Korea. A prospective research using a large scale controlled subjects will be necessary with respect to this topic.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Apnea / Arousal / Restless Legs Syndrome / Sleep Wake Disorders / Comorbidity / Medical Records / Polysomnography / Isothiocyanates / Dopamine Agonists / Sleep Apnea, Obstructive Limits: Female / Humans / Male Country/Region as subject: Asia Language: Korean Journal: Sleep Medicine and Psychophysiology Year: 2013 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Apnea / Arousal / Restless Legs Syndrome / Sleep Wake Disorders / Comorbidity / Medical Records / Polysomnography / Isothiocyanates / Dopamine Agonists / Sleep Apnea, Obstructive Limits: Female / Humans / Male Country/Region as subject: Asia Language: Korean Journal: Sleep Medicine and Psychophysiology Year: 2013 Type: Article